Tumor cells in blood samples can predict prostate cancer spread

115
blood samples can predict prostate cancer spread

Researchers have found a group of circulating tumor cells in prostate cancer patient blood samples, which are linked to the spread of the disease, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

This is the first time these cell types have been shown to be a promising marker for prostate cancer spread.

In a study of around 80 samples from men with prostate cancer, scientists at Queen Mary University looked for cells that were gaining the ability to migrate and invade through the body.

Samples with more of these cells were more likely to come from patients whose cancer had spread or was more aggressive.

This means that, in the future, these particular cells could potentially be used as a marker to monitor prostate cancer patients and predict if the disease is going to spread – alongside other monitoring techniques.

There are around 46,500 new cases of prostate cancer each year in the UK, and around 11,000 people die from the disease each year.

Researchers suggest that the number of these specific tumor cells in a patient’s sample is a good indicator of prostate cancer spreading.

By identifying these cells, which have gained the ability to move through the body, they have found a potential new way to monitor the disease.

If they’re able to replicate these studies in larger groups of people, they may be able to one day predict the risk of someone’s cancer spreading so they can make more informed treatment decisions.

Currently, there’s a need to develop better tests to identify and monitor men with aggressive prostate cancer.

This research has found a promising new marker that could one day make it to the clinic to guide treatment decisions.

Follow Knowridge Science Report on Facebook, Twitter and Flipboard.


News source: Cancer Research UK.
Figure legend: This Knowridge.com image is credited to NCRI.